-
Je něco špatně v tomto záznamu ?
Mitochondrial complex II and reactive oxygen species in disease and therapy
K. Hadrava Vanova, M. Kraus, J. Neuzil, J. Rohlena
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
Directory of Open Access Journals
od 2018
PubMed Central
od 2010
Taylor & Francis Open Access
od 1997-01-01
Medline Complete (EBSCOhost)
od 2003-02-01
ROAD: Directory of Open Access Scholarly Resources
od 1994
- MeSH
- cílená molekulární terapie * MeSH
- lidé MeSH
- mitochondriální nemoci farmakoterapie metabolismus patologie MeSH
- mitochondrie metabolismus patologie MeSH
- reaktivní formy kyslíku metabolismus MeSH
- respirační komplex II metabolismus MeSH
- transport elektronů MeSH
- zvířata MeSH
- Check Tag
- lidé MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.
Institute of Biotechnology of the Czech Academy of Sciences Prague West Czech Republic
School of Medical Science Griffith University Southport Qld Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019767
- 003
- CZ-PrNML
- 005
- 20210830101350.0
- 007
- ta
- 008
- 210728s2020 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/13510002.2020.1752002 $2 doi
- 035 __
- $a (PubMed)32290794
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Hadrava Vanova, Katerina $u Institute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic
- 245 10
- $a Mitochondrial complex II and reactive oxygen species in disease and therapy / $c K. Hadrava Vanova, M. Kraus, J. Neuzil, J. Rohlena
- 520 9_
- $a Increasing evidence points to the respiratory Complex II (CII) as a source and modulator of reactive oxygen species (ROS). Both functional loss of CII as well as its pharmacological inhibition can lead to ROS generation in cells, with a relevant impact on the development of pathophysiological conditions, i.e. cancer and neurodegenerative diseases. While the basic framework of CII involvement in ROS production has been defined, the fine details still await clarification. It is important to resolve these aspects to fully understand the role of CII in pathology and to explore its therapeutic potential in cancer and other diseases.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a transport elektronů $7 D004579
- 650 _2
- $a respirační komplex II $x metabolismus $7 D042963
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mitochondrie $x metabolismus $x patologie $7 D008928
- 650 _2
- $a mitochondriální nemoci $x farmakoterapie $x metabolismus $x patologie $7 D028361
- 650 12
- $a cílená molekulární terapie $7 D058990
- 650 _2
- $a reaktivní formy kyslíku $x metabolismus $7 D017382
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Kraus, Michal $u Institute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic
- 700 1_
- $a Neuzil, Jiri $u Institute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic $u School of Medical Science, Griffith University, Southport, Qld, Australia
- 700 1_
- $a Rohlena, Jakub $u Institute of Biotechnology of the Czech Academy of Sciences, Prague-West, Czech Republic
- 773 0_
- $w MED00192665 $t Redox report : communications in free radical research $x 1743-2928 $g Roč. 25, č. 1 (2020), s. 26-32
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32290794 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101350 $b ABA008
- 999 __
- $a ok $b bmc $g 1690554 $s 1140213
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 25 $c 1 $d 26-32 $e - $i 1743-2928 $m Redox report $n Redox Rep $x MED00192665
- LZP __
- $a Pubmed-20210728